LifeMD Statistics
Total Valuation
LifeMD has a market cap or net worth of $273.51 million. The enterprise value is $258.30 million.
| Market Cap | 273.51M |
| Enterprise Value | 258.30M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LifeMD has 41.76 million shares outstanding. The number of shares has increased by 23.87% in one year.
| Shares Outstanding | 41.76M |
| Shares Change (YoY) | +23.87% |
| Shares Change (QoQ) | +6.81% |
| Owned by Insiders (%) | 15.97% |
| Owned by Institutions (%) | 35.52% |
| Float | 35.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 32.15 |
| PS Ratio | 1.67 |
| Forward PS | 1.22 |
| PB Ratio | n/a |
| P/FCF Ratio | 35.64 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 33.66 |
Financial Position
The company has a current ratio of 0.99
| Current Ratio | 0.99 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.59 |
| Interest Coverage | -7.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -54.00% |
| Return on Capital (ROIC) | -93.44% |
| Revenue Per Employee | $775,189 |
| Profits Per Employee | -$125,413 |
| Employee Count | 211 |
| Asset Turnover | 3.34 |
| Inventory Turnover | 6.70 |
Taxes
In the past 12 months, LifeMD has paid $428,000 in taxes.
| Income Tax | 428,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.96% in the last 52 weeks. The beta is 1.24, so LifeMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +78.96% |
| 50-Day Moving Average | 7.57 |
| 200-Day Moving Average | 7.83 |
| Relative Strength Index (RSI) | 43.61 |
| Average Volume (20 Days) | 1,067,530 |
Short Selling Information
The latest short interest is 3.43 million, so 8.22% of the outstanding shares have been sold short.
| Short Interest | 3.43M |
| Short Previous Month | 3.27M |
| Short % of Shares Out | 8.22% |
| Short % of Float | 9.79% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, LifeMD had revenue of $163.56 million and -$26.46 million in losses. Loss per share was -$0.74.
| Revenue | 163.56M |
| Gross Profit | 144.28M |
| Operating Income | -17.81M |
| Pretax Income | -22.93M |
| Net Income | -26.46M |
| EBITDA | -12.79M |
| EBIT | -20.12M |
| Loss Per Share | -$0.74 |
Balance Sheet
The company has $35.11 million in cash and $19.90 million in debt, giving a net cash position of $15.21 million or $0.36 per share.
| Cash & Cash Equivalents | 35.11M |
| Total Debt | 19.90M |
| Net Cash | 15.21M |
| Net Cash Per Share | $0.36 |
| Equity (Book Value) | -845,303 |
| Book Value Per Share | -0.02 |
| Working Capital | -266,333 |
Cash Flow
In the last 12 months, operating cash flow was $16.64 million and capital expenditures -$8.96 million, giving a free cash flow of $7.67 million.
| Operating Cash Flow | 16.64M |
| Capital Expenditures | -8.96M |
| Free Cash Flow | 7.67M |
| FCF Per Share | $0.20 |
Margins
Gross margin is 88.21%, with operating and profit margins of -10.89% and -16.18%.
| Gross Margin | 88.21% |
| Operating Margin | -10.89% |
| Pretax Margin | -14.02% |
| Profit Margin | -16.18% |
| EBITDA Margin | -7.82% |
| EBIT Margin | -12.30% |
| FCF Margin | 4.69% |
Dividends & Yields
LifeMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.87% |
| Shareholder Yield | -23.87% |
| Earnings Yield | -9.68% |
| FCF Yield | 2.81% |
Analyst Forecast
The average price target for LifeMD is $13.00, which is 98.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 98.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 14, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Oct 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
LifeMD has an Altman Z-Score of -0.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.75 |
| Piotroski F-Score | 4 |